Managers / Q1 2025 · view latest →
Medicxi Ventures Management (Jersey) Ltd
CIK 0001715579 · C/O CSC FUND SERVICES (JERSEY) LIMITED, 44 ESPLANADE, ST. HELIER, Y9, JE4 9WG · 44 (0) 1534 504343
Reported Value
$438M
Q1 2025
Positions
5
Filings on Record
27
2019–present window
Filed
Apr 11, 2025
original filing
Summary
Medicxi Ventures Management (Jersey) Ltd reported $438M in U.S.-listed holdings across 5 positions for Q1 2025.
The portfolio is heavily concentrated: 260 alone accounts for 65.6% of reported value.
The book was largely unchanged from Q4 2024.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- ADR · 65.6% · $287M
- Other · 19.7% · $86M
- Common Stock · 14.8% · $65M
Quarter-over-Quarter Changes full breakdown →
Holdings — Q1 2025
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $982M | 4 | Apr 21, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $835M | 5 | Jan 23, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $744M | 5 | Oct 17, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $427M | 5 | Jul 8, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $438M | 5 | Apr 11, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $529M | 5 | Jan 23, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $529M | 4 | Oct 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $335M | 4 | Jul 16, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $449M | 5 | Apr 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $296M | 5 | Feb 1, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $313M | 6 | Oct 18, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $357M | 6 | Jul 19, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $233M | 6 | Apr 27, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $238.1B | 6 | Jan 31, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $240M | 6 | Oct 25, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $241M | 7 | Aug 3, 2022 | RESTATEMENT | changes · EDGAR ↗ |
| Q1 2022 | $369M | 7 | May 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $400M | 7 | Feb 3, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $460M | 6 | Nov 10, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $558M | 6 | Aug 3, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $172M | 5 | May 11, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $172M | 5 | Feb 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $209M | 5 | Oct 27, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $163M | 4 | Aug 7, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $77M | 3 | May 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $163M | 4 | Feb 11, 2020 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 1 additional manager.
- Francesco De Rubertis028-19836
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.